ArticleThoracic cancer2020

Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study.

Bin Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.